Pfizer reports loss as it eyes big oncology push
Pfizer reported a quarterly loss Tuesday on much lower sales of COVID-19 products as it emphasized progress on cost-cutting and drug development initiatives.
Jan 30, 2024
0
1
Pfizer reported a quarterly loss Tuesday on much lower sales of COVID-19 products as it emphasized progress on cost-cutting and drug development initiatives.
Jan 30, 2024
0
1
Pfizer said Thursday it completed a $43 billion takeover of cancer-focused biotech company Seagen that the pharma giant said would enable it to double its oncology platform.
Dec 14, 2023
0
0
Pfizer announced Tuesday that it expects to complete this week its $43 billion acquisition of cancer-focused biotech company Seagen after clearing key regulatory hurdles.
Dec 12, 2023
0
0
US drugmaker Pfizer on Friday said it would end a clinical trial of its developmental weight loss pill after high side effect rates caused most participants to stop using it.
Dec 1, 2023
0
0
A debate has broken out over whether Pfizer should have told pregnant women taking part in its maternal respiratory syncytial virus (RSV) vaccine trial that a trial of a similar GSK vaccine was stopped over a safety signal ...
Nov 15, 2023
0
1
Pfizer reported Tuesday a loss following a sharp fall in the sales of its COVID-19 vaccine and therapeutic from pandemic peaks.
Oct 31, 2023
0
1
Americans have been getting COVID treatments such as Paxlovid for free, but that's about to end.
Oct 30, 2023
0
8
Germany's BioNTech and US pharmaceutical giant Pfizer on Thursday announced "positive" results from initial trials of their combined mRNA vaccine against COVID-19 and influenza.
Oct 26, 2023
0
0
The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
The U.S. Food and Drug Administration has approved Velsipity (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).
Oct 18, 2023
0
0
Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), antibiotic Zithromax (azithromycin), Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).
Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.
On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.
This text uses material from Wikipedia, licensed under CC BY-SA